1. Home
  2. SILO vs JNVR Comparison

SILO vs JNVR Comparison

Compare SILO & JNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • JNVR
  • Stock Information
  • Founded
  • SILO 2010
  • JNVR 2018
  • Country
  • SILO United States
  • JNVR United States
  • Employees
  • SILO N/A
  • JNVR N/A
  • Industry
  • SILO Apparel
  • JNVR Finance: Consumer Services
  • Sector
  • SILO Consumer Discretionary
  • JNVR Finance
  • Exchange
  • SILO Nasdaq
  • JNVR Nasdaq
  • Market Cap
  • SILO 8.8M
  • JNVR 7.3M
  • IPO Year
  • SILO N/A
  • JNVR 2023
  • Fundamental
  • Price
  • SILO $1.66
  • JNVR $5.32
  • Analyst Decision
  • SILO
  • JNVR
  • Analyst Count
  • SILO 0
  • JNVR 0
  • Target Price
  • SILO N/A
  • JNVR N/A
  • AVG Volume (30 Days)
  • SILO 9.1M
  • JNVR 18.8K
  • Earning Date
  • SILO 02-14-2025
  • JNVR 03-27-2025
  • Dividend Yield
  • SILO N/A
  • JNVR N/A
  • EPS Growth
  • SILO N/A
  • JNVR N/A
  • EPS
  • SILO N/A
  • JNVR N/A
  • Revenue
  • SILO $72,102.00
  • JNVR $1,820,969.00
  • Revenue This Year
  • SILO $1.86
  • JNVR N/A
  • Revenue Next Year
  • SILO N/A
  • JNVR N/A
  • P/E Ratio
  • SILO N/A
  • JNVR N/A
  • Revenue Growth
  • SILO N/A
  • JNVR N/A
  • 52 Week Low
  • SILO $0.77
  • JNVR $3.37
  • 52 Week High
  • SILO $4.50
  • JNVR $11.84
  • Technical
  • Relative Strength Index (RSI)
  • SILO 52.57
  • JNVR 49.60
  • Support Level
  • SILO $1.56
  • JNVR $4.88
  • Resistance Level
  • SILO $1.89
  • JNVR $5.61
  • Average True Range (ATR)
  • SILO 0.19
  • JNVR 0.63
  • MACD
  • SILO -0.05
  • JNVR -0.03
  • Stochastic Oscillator
  • SILO 27.12
  • JNVR 24.18

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About JNVR Janover Inc.

Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.

Share on Social Networks: